Records containing: Uremic Pruritus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-10Clinical Pharmacology of LT5001 Drug Product in Hemodialysis Patients With Uremic Pruritus to Assess the Safety, Local Tolerance and Pharmacokinetics
-
CLINICAL_TRIALS study record update · 2025-12-05A Phase II Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.
-
CLINICAL_TRIALS study record update · 2025-09-12A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase 3, Clinical Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
-
CLINICAL_TRIALS study record update · 2025-09-10A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus
-
CLINICAL_TRIALS study record update · 2025-05-22A Phase 1, Open-Label, Non-Randomized, Parallel-Group Study to Characterize and Compare the Pharmacokinetics, Safety, and Tolerability of Escalating Oral Doses of Nalbuphine Hydrochloride Extended Release Tablets in End-Stage Renal Disease Patients on Hemodialysis and Matched Healthy Control Subjects
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-04-27Clinical Study to Compare The Safety and Possible Efficacy of Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis
-
CLINICAL_TRIALS study record update · 2024-08-30The Effect of Probiotics Versus Activated Charcoal in the Management of Chronic Kidney Disease Patients Suffering From Uremic Pruritus.
-
CLINICAL_TRIALS study record update · 2024-06-21A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase 3, Clinical Study of QLG2198 in Haemodialysis Adult Subjects With Moderate-to-Severe Pruritus
-
CLINICAL_TRIALS study record update · 2024-03-27This Study Aims to Compare the Efficacy of Hemp-containing Cream and a Placebo in the Treatment of Uremic Pruritus in Hemodialysis Patients. Patients Were Randomly Assigned Either the Hemp-containing Cream or a Placebo and Evaluated the WI-NRS and Skindex-10 Scores at Week 2, 4.
-
CLINICAL_TRIALS study record update · 2023-09-07Prospective Randomized Study Evaluating the Efficacy of the Spherical Absorptive Carbon AST-120 in Hemodialysis Patients With Uremic Pruritus..
-
CLINICAL_TRIALS study record update · 2023-03-23The Effect of Acupressure on Uremic Pruritus and Sleep Quality Among Patients Receiving Hemodialysis
-
CLINICAL_TRIALS study record update · 2022-09-01A Prospective, Randomized, Double-blind, Placebo-controlled Study of Thalidomide in the Treatment of Refractory Uremic Pruritus
-
CLINICAL_TRIALS study record update · 2022-08-09A Multi-center, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing Hemodialysis
-
CLINICAL_TRIALS study record update · 2022-07-20Using of Extra Virgin Olive Oil in Patient With Hemodialysis to Improve the Effect of Pruritus and Sleep Disorders
-
CLINICAL_TRIALS study record update · 2022-05-18Intermediate-Size Patient Population Expanded Access Program for Intravenous Difelikefalin
-
CLINICAL_TRIALS study record update · 2022-04-26A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus, With a 52-Week Open Label Extension
-
CLINICAL_TRIALS study record update · 2022-04-26A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus, With a 52-Week Open Label Extension
-
CLINICAL_TRIALS study record update · 2022-02-09A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
-
CLINICAL_TRIALS study record update · 2021-10-15An Open-Label, Multicenter Study to Evaluate the Safety and Effectiveness of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
-
CLINICAL_TRIALS study record update · 2021-10-14An Open-Label, Multicenter, Extension Study to Evaluate the Long Term Safety of Intravenous CR845 in Hemodialysis Patients With Chronic Kidney Disease-Associated Pruritus
-
CLINICAL_TRIALS study record update · 2021-01-28A Randomized, Double-blind, Placebo-controlled, Multisite Bridging Clinical Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet in the Treatment of Refractory Pruritus in Hemodialysis Patients
-
CLINICAL_TRIALS study record update · 2020-12-03The Treatment Effect of Chinese Medicine Formula on Uremic Pruritus
-
CLINICAL_TRIALS study record update · 2020-09-07An Open Label Extension Study of the Safety and Anti-Pruritic Efficacy of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus
-
CLINICAL_TRIALS study record update · 2020-09-07A Randomized, Double-Blind, Placebo-Controlled, Parallel, 3-Arm Study of the Safety and Anti-Pruritic Efficacy of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus
-
CLINICAL_TRIALS study record update · 2020-07-29A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus